Mark A. McPartland
Overview
Mark A. McPartland received an average of $493K in total compensation, including $284K in salary, at Vistagen Therapeutics between 2019 and 2020.
Source: SEC filing on July 27, 2020.
Related executives
We found seven more executives who work or worked at Vistagen Therapeutics.
Shawn Singh
Vistagen Therapeutics
Chief Executive Officer
Reid Adler
Vistagen Therapeutics
General Counsel
Joshua Prince
Vistagen Therapeutics
Chief Operating Officer
Cynthia Anderson
Vistagen Therapeutics
Chief Financial Officer
Jerrold Dotson
Vistagen Therapeutics
Chief Financial Officer
H Snodgrass
Vistagen Therapeutics
Chief Scientific Officer
Mark Smith
Vistagen Therapeutics